title: Addendum to report of the Global Advisory Committee on Vaccine Safety (GACVS), 10-11 June 2015¹. Safety of CYD-TDV dengue vaccine.
mesh_terms: D000293:Adolescent; D000328:Adult; D026683:Advisory Committees; D000367:Age Factors; D001208:Asia; D002648:Child; D002675:Child, Preschool; D017326:Clinical Trials, Phase III as Topic; D003715:Dengue / Q000276:immunology / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D004334:Drug Administration Schedule; D004345:Drug Industry; D005500:Follow-Up Studies; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D007843:Latin America; D008875:Middle Aged; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology
chemical_list: D053059:Dengue Vaccines; D014613:Vaccines, Attenuated